Aquatic Exercise for Cognition and Mobility in Older Adults
NCT05501249, Not applicable, Completed, Emily Dunlap
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Aquatic Exercise for Cognition and Mobility in Older Adults | ClinicalTrials.gov |
| NCT number | NCT05501249 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 25 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Emily Dunlap | ClinicalTrials.gov |
| Conditions | Aging Well, Aging Problems, Cognitive Change, Gait, Unsteady, Mobility Limitation | ClinicalTrials.gov |
| Interventions | Aquatic Integrated Cognitive Motor Training | ClinicalTrials.gov |
| First posted | 2022-08-15 | ClinicalTrials.gov |
| Last updated | 2023-03-01 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Stroop Effect Test: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Measure of working memory and attention | ClinicalTrials.gov |
| Primary | Trail Making Test A and B: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Measure of visual scanning and working memory | ClinicalTrials.gov |
| Primary | Digit Backwards Test : Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Measure of working memory capacity | ClinicalTrials.gov |
| Primary | Gait Measurements: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | 4 gait conditions (single task gait, dual task gait with head turns, dual task gait with head nods, and dual task gait count backwards by serial 7s). Gait measures collected with Strideway Gait Analysis System. | ClinicalTrials.gov |
| Primary | Functional Outcome Measures: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Timed Up and Go Test, Cognitive Timed Up and Go Test, Single Leg Balance Test, and Four Square Step Test. | ClinicalTrials.gov |
| Secondary | Vital Sign measurements: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Blood pressure and heart rate taken after 5 min supine, immediately upon standing, and 2 min after standing | ClinicalTrials.gov |
| Secondary | Anthropometric measurements: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Height and weight | ClinicalTrials.gov |
| Secondary | Neurotrophic Growth Factors: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Serum concentration of brain derived neurotrophic factor and insulin-like growth factor 1 | ClinicalTrials.gov |
| Secondary | Numeric Pain Rating Scale: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | An 11 point scale for level of pain from 0 (no pain) to 10 (severe pain). | ClinicalTrials.gov |
| Secondary | Global Rating of Change Questionnaire: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | A 15 point global rating scale for changes in domains, from -7 (a great deal worse); through 0 (no change) to +7 (a great deal better). | ClinicalTrials.gov |
| Secondary | Activities-specific balance confidence scale: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | A structured questionnaire that measures an individuals confidence performing daily activities. The minimum score is 0% (no confidence in balance) to 100% (complete confidence in balance). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 10
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)